CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 159 filers reported holding CASTLE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,192 | -50.6% | 12,800 | -59.9% | 0.00% | 0.0% |
| Q2 2023 | $437,668 | -14.9% | 31,900 | +41.0% | 0.00% | 0.0% |
| Q1 2023 | $514,017 | -59.5% | 22,624 | -58.1% | 0.00% | -75.0% |
| Q4 2022 | $1,269,865 | -59.9% | 53,945 | -55.6% | 0.00% | -63.6% |
| Q3 2022 | $3,170,000 | -3.4% | 121,548 | -18.7% | 0.01% | 0.0% |
| Q2 2022 | $3,280,000 | -43.5% | 149,429 | +10.4% | 0.01% | -8.3% |
| Q4 2021 | $5,803,000 | +19.6% | 135,367 | +85.5% | 0.01% | +9.1% |
| Q3 2021 | $4,852,000 | +54.1% | 72,966 | +69.9% | 0.01% | +57.1% |
| Q2 2021 | $3,149,000 | -50.1% | 42,938 | -53.4% | 0.01% | -56.2% |
| Q1 2021 | $6,314,000 | +34.7% | 92,224 | +32.1% | 0.02% | +23.1% |
| Q4 2020 | $4,688,000 | +2070.4% | 69,815 | +1562.3% | 0.01% | +1200.0% |
| Q3 2020 | $216,000 | -80.9% | 4,200 | -86.0% | 0.00% | -83.3% |
| Q2 2020 | $1,133,000 | – | 30,052 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |